Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-11-06 | 2021-06-03 | 128045 |
RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130310 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131069 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131706 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-22 | 2021-04-21 | 132264 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132282 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-28 | 2021-04-29 | 132660 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-18 | 2021-03-18 | 134349 |
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2021-03-04 | 2021-04-01 | 135120 |
TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2021-03-04 | 2021-04-21 | 135123 |
TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-21 | 135971 |
TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-04-21 | 2021-06-03 | 137896 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2021-05-20 | 2021-12-17 | 139731 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2021-05-20 | 2021-06-24 | 139752 |
TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-06-03 | 2021-07-09 | 140360 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-06-10 | 2021-09-02 | 140663 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141110 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145112 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 0.5G | POWDER FOR SOLUTION | Discontinued | 2019-08-08 | 2019-08-08 | 91175 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |